KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. The company also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. Pasithea Therapeutics Corp. was incorporated in 2020 and is based in Miami Beach, Florida.

$1.26
As of 09/30/2022     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  
IPO date:  09/15/2021
Outstanding shares:  26,698,688
Average volume:  145,536
Market cap:   $31,504,452
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   -35.63
PB ratio:   0.58
PS ratio:   0.00
Return on equity:   -8.93%
Net income %:   -15,535.30%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy